|
Bliss GVS Pharma Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
1648.40 Cr.
|
P/BV
|
1.63
|
Book Value (Rs.)
|
95.74
|
|
52 Week High/Low (Rs.)
|
186/103
|
FV/ML
|
1/1
|
P/E(X)
|
19.55
|
|
Bookclosure
|
25/07/2024
|
EPS (Rs.)
|
7.99
|
Div Yield (%)
|
0.32
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| No. of Equity Shares (in Lacs) | 1053.70 | 1046.91 | 1041.53 | 0.00 | 1031.47 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 10.54 | 10.47 | 10.42 | 10.37 | 10.31 |
| Total Share Capital | 10.54 | 10.47 | 10.42 | 10.37 | 10.31 |
| | | | | | |
| Reserves and Surplus | 1039.84 | 956.72 | 873.48 | 798.40 | 788.10 |
| Total Reserves and Surplus | 1039.84 | 956.72 | 873.48 | 798.40 | 788.10 |
| Employees Stock Options | 0.00 | 0.00 | 0.00 | 9.94 | 9.84 |
| Total Shareholders Funds | 1050.38 | 967.19 | 883.90 | 818.70 | 808.25 |
| Minority Interest | 41.47 | 35.79 | 33.53 | 27.76 | 19.66 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 19.85 | 35.59 | 40.69 | 23.22 | 32.60 |
| Deferred Tax Liabilities [Net] | 0.30 | 3.59 | 0.00 | 1.32 | 8.21 |
| Other Long Term Liabilities | 12.77 | 9.34 | 2.79 | 3.58 | 1.93 |
| Long Term Provisions | 4.36 | 2.54 | 2.69 | 1.07 | 2.50 |
| Total Non-Current Liabilities | 37.28 | 51.06 | 46.17 | 29.20 | 45.24 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 51.13 | 52.21 | 57.38 | 81.74 | 65.04 |
| Trade Payables | 71.42 | 60.97 | 86.39 | 92.61 | 74.22 |
| Other Current Liabilities | 48.53 | 46.64 | 46.15 | 52.03 | 55.71 |
| Short Term Provisions | 0.64 | 0.00 | 3.34 | 6.72 | 8.66 |
| Total Current Liabilities | 171.72 | 159.82 | 193.26 | 233.09 | 203.64 |
| | | | | | |
| Total Capital And Liabilities | 1300.84 | 1213.87 | 1156.85 | 1108.75 | 1076.79 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 397.69 | 362.24 | 370.80 | 273.36 | 226.12 |
| Intangible Assets | 0.23 | 0.11 | 0.23 | 0.38 | 0.58 |
| Capital Work-In-Progress | 20.71 | 7.83 | 2.80 | 22.15 | 2.39 |
| Fixed Assets | 418.63 | 370.17 | 373.83 | 295.89 | 229.09 |
| Goodwill On Consolidation | 7.71 | 7.71 | 7.71 | 7.71 | 7.71 |
| Non-Current Investments | 4.38 | 3.61 | 2.84 | 2.39 | 0.01 |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 3.33 | 0.00 | 0.00 |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 2.10 |
| Other Non-Current Assets | 43.60 | 20.75 | 71.78 | 26.72 | 72.67 |
| Total Non-Current Assets | 474.33 | 402.25 | 459.49 | 332.71 | 311.59 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 0.00 | 0.56 | 4.96 | 0.00 | 0.00 |
| Inventories | 125.73 | 118.45 | 103.06 | 123.94 | 98.93 |
| Trade Receivables | 438.36 | 404.35 | 385.17 | 392.75 | 463.82 |
| Cash And Cash Equivalents | 213.31 | 215.62 | 102.99 | 177.53 | 144.55 |
| Short Term Loans And Advances | 0.04 | 0.07 | 0.10 | 0.13 | 0.16 |
| OtherCurrentAssets | 49.07 | 72.58 | 101.09 | 81.69 | 57.75 |
| Total Current Assets | 826.51 | 811.62 | 697.37 | 776.03 | 765.20 |
| | | | | | |
| Total Assets | 1300.84 | 1213.87 | 1156.85 | 1108.75 | 1076.79 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 56.89 | 11.59 | 22.70 | 30.31 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 0.00 | 4.91 | 4.91 | 4.91 | 4.91 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.51 | 0.00 | 0.00 |
| Non-Current Investments Unquoted Book Value | 0.00 | 3.61 | 2.33 | 2.39 | 0.01 |
